HR Positive/HER2 Low Breast Cancer Clinical Trials
1 recruiting
Showing 1–2 of 2 trials
Recruiting
Phase 2
Neoadjuvant Therapy Combined With Trastuzumab Rezetecan and Toripalimab for HR+/HER2-low Breast Cancer (NEOTORCH-BREAST 08)
HR Positive/HER2 Low Breast Cancer
First Affiliated Hospital of Zhejiang University111 enrolled5 locationsNCT07383818
Recruiting
Phase 2
SHR-A1811 Alone or in Combination With Adebrelimab as Neoadjuvant Treatment in HR Positive/HER2 Low Breast Cancer
HR Positive/HER2 Low Breast Cancer
Shengjing Hospital93 enrolled1 locationNCT06340230